These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1025046)

  • 1. Dissolution properties of digoxin tablets marketed in the Republic of Ireland.
    Corrigan OI; Timoney RF
    Ir Med J; 1976 Feb; 69(3):60. PubMed ID: 1025046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improved bioavailability of Israeli digoxin tablets with increased dissolution rates].
    Halkin H; Farfel Z; Saginer P; Millman P; Gibbor Y
    Harefuah; 1977 Oct; 93(7-8):189-91. PubMed ID: 924245
    [No Abstract]   [Full Text] [Related]  

  • 3. Digoxin tablets--a review of the bioavailability problems.
    Sim SK
    Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
    Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation of bioavailability to the dissolution rate of experimentally produced digoxin tablets.
    Johnson BF; Greer H; McCrerie JA; Bye C; Fowle AS
    Postgrad Med J; 1974 Nov; 50 Suppl 6():48-52. PubMed ID: 4617868
    [No Abstract]   [Full Text] [Related]  

  • 6. Physical and dissolution characteristics and bio-availability of five brands of digoxin tablets.
    Fletcher S; Summers RS
    S Afr Med J; 1980 Apr; 57(14):530-3. PubMed ID: 7368019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological availability of very rapidly dissolving digoxin tablets.
    Shaw TR; Raymond K; Greenwood H
    Postgrad Med J; 1974 Nov; 50 Suppl 6():55-9. PubMed ID: 4459890
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro characterisation of digoxin tablets marketed in India.
    Bansinath M; Shukla VK; Chopra KS; Mathur VS
    Indian J Med Res; 1983 Mar; 77():395-400. PubMed ID: 6874025
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of digoxin tablets in relation to their dissolution in vitro.
    Ylitalo P; Wilen G; Lundell S
    J Pharm Sci; 1975 Jul; 64(7):1264-6. PubMed ID: 1151696
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of digoxin-tablet dissolution-rate with biological availability.
    Reissell P; Ojala K; Manninen V; Sothman A
    Br J Clin Pharmacol; 1977 Apr; 4(2):235-6. PubMed ID: 861138
    [No Abstract]   [Full Text] [Related]  

  • 13. Single dose bioavailability of two different digoxin tablets.
    Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
    Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardioactive glycosides as a biopharmaceutical problem].
    Frömming KH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():29-33. PubMed ID: 611966
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of variable bioavailability as an international problem: a review of the earlier studies.
    Munro-Faure AD; Fowle AS; Fox J; Johnson BF; Lader S
    Postgrad Med J; 1974 Nov; 50 Suppl 6():14-8. PubMed ID: 4459882
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Bio availability of digoxin and derivatives.
    Rietbrock N; Guggenmos J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R80. PubMed ID: 4276634
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biopharmaceutical characteristics of digoxin tablets].
    Avico U; Signoretti Ciranni E; Zuccaro P; Cingolani E; Foschi F; Paciaroni E
    Boll Chim Farm; 1976 Jun; 115(6):432-9. PubMed ID: 1008948
    [No Abstract]   [Full Text] [Related]  

  • 19. Discrepancy between solution and bioavailability of digoxin tablets.
    Ylitalo P; Wilén G; Lundell S
    Lancet; 1975 Mar; 1(7909):744. PubMed ID: 47503
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.